Javascript must be enabled to continue!
A CASE SERIES: AYURVEDIC MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA)
View through CrossRef
Background- Bronchial Asthma is a chronic inammatory disease of airways of lungs. It is characterized
by various and recurring symptoms reversible airow obstruction and Bronchospasm. Modern science
has developed many medicines like Doxophylline, Theophylline, various Corticosteroids, and Salbutamol. Yet these medicines
come up with many adverse effects and they are also target specic. In Ayurveda Bronchial asthma is co-related with Tamaka
Shvasa. Tamaka Shvasa is mainly caused due to the Vata and Kapha Dosha. Hence in management of Tamaka Shvasa,
Vataghna and Kaphagna Chikita are needed. Kantakari is Vata-Kaphagna in nature. The drug is used as anti-asthmatics,
hypoglycemic, anti-histaminics, anti-inammatory, anti-spasmodic, hypotensive, anti-pyretic activity. Case series of Methods10 patients were managed with Kantakari Siddha Ghruta Snehapana followed by Virechana and Shamana Chikitsa.
Assessement was done on the basis of PFT and IgE. Improvement in PFT and Decreased IgE level w Result- ill be stated in full
paper. After administration of Kantakari Sidha Ghruta, Virechana and Shamana Chikitsa, Discussion And Conclusionchanges in PFT observed with changes in IgE, which is mention in full paper. ON this we concluded that Ayurvedic treatment is
benecial in treatment of Tamaka Shvasa.
World Wide Journals
Title: A CASE SERIES: AYURVEDIC MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA)
Description:
Background- Bronchial Asthma is a chronic inammatory disease of airways of lungs.
It is characterized
by various and recurring symptoms reversible airow obstruction and Bronchospasm.
Modern science
has developed many medicines like Doxophylline, Theophylline, various Corticosteroids, and Salbutamol.
Yet these medicines
come up with many adverse effects and they are also target specic.
In Ayurveda Bronchial asthma is co-related with Tamaka
Shvasa.
Tamaka Shvasa is mainly caused due to the Vata and Kapha Dosha.
Hence in management of Tamaka Shvasa,
Vataghna and Kaphagna Chikita are needed.
Kantakari is Vata-Kaphagna in nature.
The drug is used as anti-asthmatics,
hypoglycemic, anti-histaminics, anti-inammatory, anti-spasmodic, hypotensive, anti-pyretic activity.
Case series of Methods10 patients were managed with Kantakari Siddha Ghruta Snehapana followed by Virechana and Shamana Chikitsa.
Assessement was done on the basis of PFT and IgE.
Improvement in PFT and Decreased IgE level w Result- ill be stated in full
paper.
After administration of Kantakari Sidha Ghruta, Virechana and Shamana Chikitsa, Discussion And Conclusionchanges in PFT observed with changes in IgE, which is mention in full paper.
ON this we concluded that Ayurvedic treatment is
benecial in treatment of Tamaka Shvasa.
Related Results
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
Prevalence of Comorbidities among United States Adults with asthma and Their Association with Asthma Severity
AbstractIntroductionThe burden of comorbidities in asthma patients significantly affects management strategies and outcomes. This study aimed to analyze the prevalence and trends o...
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
Asthma, a ubiquitous chronic respiratory ailment, stands as a formidable global health concern, affecting millions of individuals across the world. This widespread condition, marke...
Management of Patients with Bronchial Asthma: GINA 2021
Management of Patients with Bronchial Asthma: GINA 2021
Бронхиальная астма является широко распространенным гетерогенным заболеванием легких, характеризующимся хроническим воспалением дыхательных путей, наличием изменяющихся по времени ...
Quality of life and its relation to pediatric asthma severity
Quality of life and its relation to pediatric asthma severity
Abstract
Background
Bronchial asthma is a global health problem that negatively affects the quality of life (QOL) of both children and their caregiv...

